Evidence-based recommendations on moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment.

In August 2017, we updated this guidance with changes to costs and savings figures.

NICE has also produced a medtech innovation briefing on moorLDLS-BI for burn depth assessment, which uses a line‑scanning approach to assess burn depth.

Implementation

NICE has developed tools, in association with relevant stakeholders, to help organisations put this guidance into practice.

Is this guidance up to date?

We reviewed the evidence in October 2021. We found nothing new that affects the recommendations in this guidance.

Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.

Guidance development process

How we develop NICE medical technologies guidance

NICE medical technologies guidance addresses specific technologies notified to NICE by sponsors. The ‘case for adoption’ is based on the claimed advantages of introducing the specific technology compared with current management of the condition. This case is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.

Clinical coding recommendations

Coding relevant to this guidance

SNOMED CT

Procedure

252452009 | Laser doppler (procedure)
281831000000101 | Laser doppler ultrasound velocimetry (procedure)

Device

13031701000001108 | moorLDI2-BI cutaneous microcirculation single point laser Doppler imaging device (Moor Instruments) (physical object)

701422002 | Cutaneous microcirculation laser Doppler imaging device (physical object)

  • National Institute for Health and Care Excellence (NICE)